Structural and Enzymatic Comparison of Faecalibacterium prausnitzii GH31 α-Glycosidases
Loading...
Date
2022-05-02
Authors
Jewczynko, Anna
Journal Title
Journal ISSN
Volume Title
Publisher
University of Waterloo
Abstract
The gut microbiome is home to thousands of species of bacteria, that are essential for human digestion, immunity and physiology. Faecalibacterium prausnitzii makes up about 5% of a healthy human gut microbiome and a lower abundance of this bacterium has been found in patients with IBD and Crohn’s disease. Among an extensive repertoire of carbohydrate active enzymes, F. prausnitzii has 2 GH31 enzymes, which are from the same family as Sucrase-Isomaltase and Maltase-Glucoamylase, human digestive enzymes with overlapping and distinguishing substrate specificities. This thesis aims to characterize the substrate specificity, preference and inhibition sensitivity of F. prausnitzii GH31 α-glucosidases to better understand the structural features of GH31 enzymes and the biological capabilities of these bacteria. In this thesis, AlphaFoldV2.1.0 was used to create computational models of F. prausnitzii α-glucosidases, and the substrate specificity, enzyme kinetics and inhibition parameters are reported. Structurally, these α-glucosidases have the same identified conserved N-terminal and (β/α)8 barrel domains, but FpAG1 has an additional conserved domain of unknown function at the C-terminus which is not found in the FpAG2 structure. Both FpAG1 and FpAG2 have α-glucosidase and oligo-1,6-glucosidase activity. The comparative kinetic studies show that FpAG1 has a greater preference for α-1,6 glycosidic linkages, and FpAG2 has a greater preference for α-1,4 glycosidic linkages. The comparative inhibition studies show that the tested α-glucosidase inhibitors, acarbose, miglitol and kotalanol, are more potent in FpAG2 than FpAG1, and acarbose is a weak inhibitor of F. prausnitzii α-glucosidases. Distinguishing binding affinities of miglitol and kotalanol in these GH31 enzymes suggest structural differences in the FpAG1 and FpaG2 active sites. Gaining insight on the GH31 α-glucosidases as a component of F. prausnitzii metabolism can further our understanding of this community in the human gut microbiome.